Medications such as Wegovy and Ozempic, both of which contain semaglutide, have become hugely popular, not least because they can help people lose more than 10% of their body weight
Once-weekly semaglutide 1 mg was tied to a reduction in total daily insulin dose among adults with type 1 diabetes, researchers reported in a post hoc analysis of the ADJUST-T1D trial published in Diabetes Care
This is the settlement value estimate for the top tier Ozempic cases, which would be those in which the plaintiff suffered severe gastroparesis or death
Another option is to try a different GLP-1 receptor agonist to help with weight loss
Patients who carry 80, 100, or 200+ pounds of excess weight rarely reach their goal on Rybelsus alone
Medication selection also depends on health history, side-effect tolerance, diabetes status, pregnancy plans, medication interactions, insurance, cost, availability, and individual treatment goals